Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

By sjmartinez • April 28, 2023

Rastogi A, Januzzi JL Jr. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease. J Clin Med. 2023 Apr 12;12(8):2824. doi: 10.3390/jcm12082824. PMID: 37109162.

Tags: cardiac remodeling, cardiovascular outcomes, Chronic kidney disease, glomerular pressure, heart failure, mechanism of action, Nephrology, Publications, renal outcomes, sodium-glucose cotransporter-2 inhibitors, sympathetic nervous system, Type 2 diabetes

Reproductive Planning and Preconception Counseling in Kidney Disease (REPKID):A Cross-Sectional Survey

Lee G, Al Baghdadi M, Iraheta YA, Kwan L, Han CS, Nobakht N. Reproductive Planning and Preconception Counseling in Kidney Disease (REPKID):A Cross-Sectional Survey. Kidney[...]

Fabry Disease: Current Perspectives on Diagnosis and Management Strategies

Norouzi S, Ghozloujeh ZG, Lerma E, Hwang MR, Rastogi A. Fabry Disease: Current Perspectives on Diagnosis and Management Strategies. Adv Kidney Dis Health. 2026 Jan;33(1):92-102.[...]

The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and Gender Diverse Veterans

Jackson N, Buljubasic N, Kalantar-Zadeh K, Wolfe HL, Neugarten J, Hashemi L. The Effect of Gender-Affirming Hormone Treatment on Kidney Function Trajectories in Transgender and[...]